Onconome Announces Completion of Breakthrough Research Study Highlighting New Blood Test for Prostate Cancer

Onconome Announces Completion of Breakthrough Research Study Highlighting New Blood Test for Prostate Cancer: "Onconome, Inc., a privately held Seattle based biotechnology company, today announced the publication of a groundbreaking research study conducted at The Johns Hopkins School of Medicine. The study relates to a newly discovered blood protein, ProstaMark(R) EPCA-2 (Early Prostate Cancer Antigen) that could change the way men are screened for prostate cancer, a disease which kills more than 25,000 men each year."